Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review

OBJECTIVE: This study aims to systematically review recent economic evaluations of elbasvir/grazoprevir (EBR/GZR) for chronic hepatitis C (CHC), to critically appraise the reporting quality and to summarize the results. METHODS: A literature search was undertaken using Medline, Embase, the Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinyu, Guo, Min, Ke, Lei, You, Ruxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136222/
https://www.ncbi.nlm.nih.gov/pubmed/35646774
http://dx.doi.org/10.3389/fpubh.2022.836986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136222/
https://www.ncbi.nlm.nih.gov/pubmed/35646774
http://dx.doi.org/10.3389/fpubh.2022.836986

Ejemplares similares